1. Home
  2. NOMD vs NBTX Comparison

NOMD vs NBTX Comparison

Compare NOMD & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nomad Foods Limited

NOMD

Nomad Foods Limited

N/A

Current Price

$11.74

Market Cap

1.7B

ML Signal

N/A

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

N/A

Current Price

$30.45

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NOMD
NBTX
Founded
2014
2003
Country
United Kingdom
France
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
NOMD
NBTX
Price
$11.74
$30.45
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$13.82
★ $54.24
AVG Volume (30 Days)
★ 1.2M
126.0K
Earning Date
11-04-2026
09-24-2026
Dividend Yield
★ 5.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.31
$50.69
P/E Ratio
$8.38
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.99
$19.14
52 Week High
$13.08
$57.14

Technical Indicators

Market Signals
Indicator
NOMD
NBTX
Relative Strength Index (RSI) 50.11 52.98
Support Level $11.61 $30.15
Resistance Level $12.18 $35.17
Average True Range (ATR) 0.28 1.97
MACD -0.01 0.47
Stochastic Oscillator 13.07 67.29

Price Performance

Historical Comparison
NOMD
NBTX

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: